Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 40
Filter
1.
Mycopathologia ; 189(4): 57, 2024 Jun 15.
Article in English | MEDLINE | ID: mdl-38878212

ABSTRACT

A 67 year-old male was admitted in the ICU because of multi-organ failure due to sepsis secondary to Fournier's gangrene. He had sustained radical prostatectomy in the last 48 hours. Peritoneal fluid and fatty tissue biopsies grew Aspergillus Fumigatus without concomitant pulmonary involvement. Postoperative acquisition via exogenous and endogenous routes is discussed, as this nosocomial entity is very rarely reported apart from peritoneal dialysis, especially in non-immunosuppressed patients.


Subject(s)
Aspergillosis , Aspergillus fumigatus , Peritonitis , Postoperative Complications , Humans , Male , Aspergillus fumigatus/isolation & purification , Aged , Peritonitis/microbiology , Peritonitis/pathology , Peritonitis/etiology , Aspergillosis/microbiology , Aspergillosis/diagnosis , Aspergillosis/pathology , Aspergillosis/etiology , Postoperative Complications/microbiology , Postoperative Complications/etiology , Prostatectomy/adverse effects
2.
Rev Med Liege ; 74(9): 461-464, 2019 Sep.
Article in French | MEDLINE | ID: mdl-31486315

ABSTRACT

The treatment of spinal muscular atrophy (SMA) has considerably changed over the last 3 years. Several approaches that aim to increase the deficient SMN protein have demonstrated an efficacy that is inversely correlated with disease duration. In this context, newborn screening (NBS) is increasingly considered as the next step in several countries or regions. In 2018, we initiated a pilot study for NBS of SMA in French- and German-speaking Belgium. We aim to evaluate the feasibility, the efficacy, and the cost-effectiveness of such a program. Initially covering the region of Liege, the program was recently extended to the whole Southern Belgium and currently covers about 55.000 newborns per year. On June 1st 2019, 35.000 newborns had been screened and 5 affected babies were identified and referred to neuromuscular centers for early treatment. A full evaluation of the program will take place after three years to consider the inclusion of SMA screening in the publically-funded NBS program in Southern Belgium.


La prise en charge de l'amyotrophie spinale antérieure (SMA) a considérablement évolué au cours des trois dernières années. Les différents essais visant à augmenter la production de la protéine SMN déficitaire dans la SMA ont systématiquement montré une efficacité inversement proportionnelle à la durée de la maladie. Dès lors, l'implémentation d'un programme de dépistage néonatal s'est rapidement imposée comme une évidence médico-économique dans de nombreux pays. Dans ce contexte, nous avons initié un programme de dépistage néonatal pour la SMA en Belgique francophone et germanophone. En 2018, une étude pilote de trois ans visant à évaluer la faisabilité, l'efficacité et la rentabilité du screening a été initiée au sein du centre de dépistage de Liège. L'étude a récemment été étendue à l'ensemble de la Fédération Wallonie-Bruxelles (FWB) pour couvrir environ 55.000 naissances annuelles. Au 1er juin 2019, 35.000 bébés ont été dépistés et cinq nouveau-nés atteints de SMA ont été identifiés. Tous ont été immédiatement référés pour assurer leur prise en charge dans un centre de référence pour les maladies neuromusculaires. Une évaluation complète du programme aura lieu à l'issue de la phase pilote, afin d'envisager que la SMA soit reconnue comme maladie officielle du programme de dépistage néonatal en FWB.


Subject(s)
Muscular Atrophy, Spinal , Belgium/epidemiology , Humans , Infant , Infant, Newborn , Muscular Atrophy, Spinal/diagnosis , Muscular Atrophy, Spinal/epidemiology , Neonatal Screening , Pilot Projects
3.
IDCases ; 14: e00416, 2018.
Article in English | MEDLINE | ID: mdl-30191127

ABSTRACT

Chronic meningococcemia is an uncommon disorder, representing a diagnostic challenge. Classically, this pathology would be considered in young adults with a history of episodes of fever, disseminated cutaneous vasculitis and arthralgia. Exact and rapid diagnosis is often further challenged by the fact that routine microbiological investigations frequently failed to identify incriminated micro-organism, Neisseria meningitidis. Here we present the case of a young man not presenting with the classical triad.

4.
J Morphol ; 271(7): 793-813, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20544873

ABSTRACT

Although the monophyly of Nemertea is strongly supported by unique morphological characters and results of molecular phylogenetic studies, their ingroup relationships are largely unresolved. To contribute solving this problem we studied sperm ultrastructure of 12 nemertean species that belong to different subtaxa representing the commonly recognized major monophyletic groups. The study yielded a set of 26 characters with an unexpected variation among species of the same genus (Tubulanus and Procephalothrix species), whereas other species varied in metric values or only one character state (Ramphogordius). In some species, the sperm nucleus has grooves (Zygonemertes virescens, Amphiporus imparispinosus) that may be twisted and give a spiral shape to the sperm head (Paranemertes peregrina, Emplectonema gracile). To make the characters from sperm ultrastructure accessible for further phylogenetic analyses, they were coded in a character matrix. Published data for eight species turned out to be sufficiently detailed to be included. Comparative evaluation of available information on the sperm ultrastructure suggests that subtaxa of Heteronemertea and Hoplonemertea are supported as monophyletic by sperm morphology. However, the data do not provide information on the existing contradictions regarding the internal relationships of "Palaeonemertea." Nevertheless, our study provides evidence that sperm ultrastructure yields numerous potentially informative characters that will be included in upcoming phylogenetic analyses.


Subject(s)
Invertebrates/cytology , Invertebrates/ultrastructure , Spermatozoa/ultrastructure , Animals , Cluster Analysis , Male
5.
East Afr Med J ; 84(9): 420-8, 2007 Sep.
Article in English | MEDLINE | ID: mdl-18074960

ABSTRACT

OBJECTIVES: To determine the aetiological agents of pulmonary infections in HIV-infected Tanzanians and to correlate the causative agents with clinical, radiographic features, and mortality. DESIGN: A prospective study. SETTING: Kilimanjaro Christian Medical Centre (KCMC), Tanzania. SUBJECTS: Bronchoalveolar lavage fluid (BAL) were obtained from 120 HIV infected patients with pulmonary infections. BAL for causative agents was analysed and correlated with clinical and radiographic features, and one-month outcome. RESULTS: Causative agents were identified in 71 (59.2%) patients and in 16 of these patients, multiple agents were found. Common bacteria were identified in 35 (29.2%) patients, Mycobacterium tuberculosis in 28 (23.3%), Human Herpes Virus 8 (HHV8) in 12 (10%), Pneumocystis jiroveci in nine (7.5%) and fungi in five (4.2%) patients. Median CD4 T cell count of the patients with identified causes was 47 cells/microl (IQR 14-91) and in the 49 patients with undetermined aetiology was 100 cells/ microl (IQR 36-188; p = 0.01). Micronodular chest radiographic lesions were associated with presence of M. tuberculosis (p = 0.002). The one-month mortality was 20 (16.7%). The highest mortality was associated with HHV8 (41.7%) and M. tuberculosis (32.1%). Mortality in patients with undetermined aetiology was 11.3%. No death occurred in patients with PCP. CONCLUSION: In this population of severely immunosuppressed HIV-infected patients with pulmonary infection a variety of causative agents was identified. Micronodular radiographic lesions were indicative of TB. High mortality was associated with M. tuberculosis or HHV8. No death occurred in patients with P. jiroveci infection.


Subject(s)
Bronchoscopy , HIV Infections/complications , Respiratory Tract Infections/etiology , AIDS-Related Opportunistic Infections , Adult , Bacterial Infections/microbiology , CD4 Lymphocyte Count , Comorbidity , Female , Humans , Male , Prospective Studies , Respiratory Tract Infections/diagnosis , Respiratory Tract Infections/microbiology , Risk Factors , Tanzania , Virus Diseases/microbiology
7.
Eur Heart J ; 23(23): 1854-60, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12445534

ABSTRACT

AIMS: Physical reconditioning of patients with chronic heart failure (CHF) improves exercise capacity and restores endothelial function and skeletal muscle changes. The effects of 4 months combined endurance/resistance exercise training on cytokines and cytokine receptors in patients with CHF were studied. In addition, changes in submaximal and maximal exercise performance were addressed. METHODS AND RESULTS: Twenty-three patients with stable CHF due to coronary artery disease (CAD, n=12) or idiopathic dilated cardiomyopathy (IDCM, n=11) were trained for 4 months. Blood sampling for measurement of plasma concentrations (ELISA) of interleukin (IL)-6, tumour necrosis factor (TNF)-alpha, soluble TNF receptor 1 (sTNFR1) and 2 (sTNFR2), as well as cardiopulmonary exercise testing were performed at baseline and after 4 months. Training induced a significant decrease in sTNFR1 (P=0.02) for the total population, and in both sTNFR1 (P=0.01) and sTNFR2 (P=0.02) concentrations for the CAD group only. IL-6 and TNF-alpha levels were not altered. Cytokine concentrations remained unchanged in an untrained age- and sex-matched control group. NYHA functional class, submaximal and maximal workrate were significantly improved in both patient groups. Oxygen uptake at the anaerobic threshold (P=0.002) and at peak exercise increased in the CAD patients only (P=0.008). CONCLUSION: Besides an overall beneficial effect on exercise capacity, combined endurance/resistance exercise training has an anti-inflammatory effect in patients with CHD and CAD.


Subject(s)
Coronary Disease/rehabilitation , Exercise Therapy/methods , Heart Failure/rehabilitation , Receptors, Tumor Necrosis Factor/blood , Adult , Aged , Aged, 80 and over , Coronary Disease/blood , Cytokines/blood , Exercise Tolerance , Female , Heart Failure/blood , Humans , Interleukin-6/blood , Male , Middle Aged , Oxygen Consumption , Physical Endurance
8.
J Clin Microbiol ; 36(1): 90-3, 1998 Jan.
Article in English | MEDLINE | ID: mdl-9431927

ABSTRACT

Isolates of Pneumocystis carinii f. sp. hominis were examined from six individuals who died of P. carinii pneumonia between 1968 and 1981 and who had underlying immunodeficiencies which were not due to human immunodeficiency virus infection. DNA sequence variation was analyzed in the genes encoding the mitochondrial large subunit rRNA (mt LSU rRNA), the internal transcribed spacer (ITS) regions of the nuclear rRNA, the arom locus, and the mitochondrial small subunit rRNA. No major variations were observed when these isolates were compared to isolates from HIV-infected individuals. A small number of minor differences were detected. A new position at which variation occurred in the mt LSU rRNA was observed in one sample. Three new ITS sequence types were identified. A total of nine different ITS sequence types were found in the six samples. Mixed infection with different ITS sequence types of P. carinii f. sp. hominis was observed in four of the six samples. The ITS locus was the most informative of the four loci for distinguishing among the isolates of P. carinii f. sp. hominis. The data suggest that isolates of P. carinii f. sp. hominis from before the AIDS pandemic are genetically very similar to those currently found in HIV-infected individuals.


Subject(s)
AIDS-Related Opportunistic Infections/microbiology , Pneumocystis/classification , Adult , Child , Genotype , Humans , Pneumocystis/genetics , RNA, Ribosomal/analysis , Transcription, Genetic
10.
Eur J Clin Invest ; 27(4): 333-9, 1997 Apr.
Article in English | MEDLINE | ID: mdl-9134383

ABSTRACT

Concentrations and ex vivo production of interleukin 1 beta (IL-1), tumour necrosis alpha (TNF), interleukin 6 (IL-6), interleukin-1 receptor antagonist (IL-1RA) and TNF soluble receptors (sTNF-receptors, P55 and P75) were measured in bronchoalveolar lavage (BAL) fluid and blood in 23 HIV-seropositive (HIV+) patients with Pneumocystis carinii pneumonia (PCP) and compared with values found in healthy HIV-seronegative (HIV-) controls and asymptomatic HIV+ subjects. Concentrations of the proinflammatory cytokine IL-1 beta were increased in BAL fluid of HIV+ patients with PCP (184 +/- 47 pg mL-1) compared with undetectable levels in healthy control subjects (P = 0.0001). In plasma of these patients higher concentrations of the anti-inflammatory cytokine IL-1RA were found during acute PCP than after recovery (2.1 +/- 0.7 vs. 0.5 +/- 0.2 ng mL-1, P = 0.01). No correlations could be found between cytokine concentrations and clinical severity of the infection. Corticosteroid treatment did not influence cytokine concentrations in BAL or blood, nor did it suppress the production in alveolar cells. In whole-blood cultures, however, lipopolysaccharide (LPS)-stimulated production was significantly suppressed for IL-1 (1.3 vs. 5.5 ng mL-1, P = 0.009) and for IL-6 (0.6 vs. 2.5 ng mL-1, P = 0.01). The overall data show that in HIV+ patients with PCP (similar to what we had found previously in HIV-patients with PCP) proinflammatory cytokines are more prominently present in BAL, whereas anti-inflammatory reaction is predominant in the circulation.


Subject(s)
AIDS-Related Opportunistic Infections/immunology , Bronchoalveolar Lavage Fluid/chemistry , Cytokines/analysis , Pneumonia, Pneumocystis/immunology , Adrenal Cortex Hormones/pharmacology , Adult , Cytokines/biosynthesis , Cytokines/blood , Female , Humans , Interleukin 1 Receptor Antagonist Protein , Male , Middle Aged , Receptors, Tumor Necrosis Factor/analysis , Sialoglycoproteins/analysis
11.
J Leukoc Biol ; 60(6): 710-5, 1996 Dec.
Article in English | MEDLINE | ID: mdl-8975872

ABSTRACT

To gain more insight into the role of cytokines in Pneumocystis carinii pneumonia (PCP) we followed pro-inflammatory cytokine profiles in rats with steroid-induced PCP at 2-week intervals. The cytokines measured were immunoreactive interleukin-1beta (IL-1beta), bioactive interleukin-6 (IL-6), and tumor necrosis factor alpha (TNF-alpha). In vivo cytokine concentrations were determined in three compartments, i.e., bronchoalveolar lavage (BAL) fluid, lung homogenates, and plasma. Lipopolysaccharide (LPS) -stimulated cytokine production by alveolar cells and in whole-blood cultures was measured ex vivo. P carinii load and host inflammatory response, as determined by lung/body weight ratio and 111indium-IgG biodistribution were monitored throughout developing PCP. IL-1beta was elevated in lung homogenates (600, range <20-1260 pg/mL) and IL-6 in BAL fluid (48, range <20-115 pg/mL), whereas the pro-inflammatory cytokine concentrations were not increased in plasma. Thus in rats with PCP elevated pro-inflammatory cytokine concentrations were found to be restricted to the lung compartments. Corticosteroids did not significantly influence cytokine concentrations, but showed profound inhibitory effects on ex vivo cytokine production. The LPS-stimulated cytokine production by alveolar cells gradually decreased during the 6 weeks after the start of the steroid injections, whereas the production in whole blood cultures was immediately and completely suppressed.


Subject(s)
Cytokines/metabolism , Lung/immunology , Pneumonia, Pneumocystis/physiopathology , Animals , Bronchoalveolar Lavage Fluid/immunology , Cells, Cultured , Cytokines/blood , Female , Hydrocortisone/pharmacology , Immunosuppression Therapy , Interleukin-1/biosynthesis , Interleukin-6/biosynthesis , Rats , Rats, Sprague-Dawley , Time Factors , Tumor Necrosis Factor-alpha/biosynthesis
12.
J Eukaryot Microbiol ; 43(5): 43S, 1996.
Article in English | MEDLINE | ID: mdl-8822846

ABSTRACT

P.carinii molecular epidemiology appears a new interesting investigational field to understand distribution and incidence of isolates from different geographical locations. Recently a typing system, the Type Specific Oligoblotting (TSO) based on 6 different sequences of the Internal Transcribed Spacers (ITSs) of P.carinii rRNA has been developed [1]. By using P.carinii ITSs nested PCR followed by TSO hybridization we have typed 55 lung derived specimens collected in Italy, The Netherlands and sub-Saharian Africa from pts with microscopically detected P.carinii pneumonia.


Subject(s)
Mycological Typing Techniques , Pneumocystis/classification , Polymerase Chain Reaction/methods , AIDS-Related Opportunistic Infections/epidemiology , AIDS-Related Opportunistic Infections/microbiology , Adult , Bronchoalveolar Lavage Fluid/microbiology , DNA, Fungal/analysis , Female , Humans , Italy/epidemiology , Male , Netherlands/epidemiology , Pneumocystis/genetics , Pneumocystis/isolation & purification , Pneumonia, Pneumocystis/epidemiology , Pneumonia, Pneumocystis/microbiology , Tanzania/epidemiology
13.
J Clin Microbiol ; 34(2): 282-5, 1996 Feb.
Article in English | MEDLINE | ID: mdl-8789001

ABSTRACT

Two monoclonal antibodies which can be used for the unambiguous identification by fluorescence microscopy of Encephalitozoon intestinalis spores in clinical specimens are described. Monoclonal antibody Si91 is specific for the extruded polar filament, and Si13 recognizes the surfaces of E. intestinalis spores. No cross-reaction with spores of Encephalitozoon hellem was observed. Immunogold electron microscopy confirmed the specific reactivities of both antibodies. Combined in an indirect immunofluorescence assay, these antibodies are used to identify spores in feces. Although there was some cross-reaction with fecal bacteria and fungi, the typical morphology of the extruded polar filaments enabled proper identification of the E. intestinalis spores. Parasites could also be demonstrated to be present in urine, nasal swabs, lung brush biopsy specimens, and bronchoalveolar lavage fluid from a patient with disseminated infection with E. intestinalis. The use of these monoclonal antibodies facilitates the detection and species determination of E. intestinalis in clinical specimens.


Subject(s)
Antibodies, Monoclonal , Antibodies, Protozoan , Encephalitozoon/immunology , Encephalitozoonosis/diagnosis , AIDS-Related Opportunistic Infections/complications , AIDS-Related Opportunistic Infections/diagnosis , AIDS-Related Opportunistic Infections/parasitology , Animals , Antigens, Protozoan/isolation & purification , Encephalitozoon/isolation & purification , Encephalitozoon/ultrastructure , Encephalitozoonosis/complications , Encephalitozoonosis/parasitology , Fluorescent Antibody Technique, Indirect , Humans , Microscopy, Immunoelectron , Protozoan Proteins/immunology , Protozoan Proteins/isolation & purification , Spores/immunology , Spores/isolation & purification , Spores/ultrastructure
14.
Eur J Clin Invest ; 26(2): 159-66, 1996 Feb.
Article in English | MEDLINE | ID: mdl-8904526

ABSTRACT

Concentrations and ex vivo production of interleukin-1beta (IL-1beta), tumour necrosis factor-alpha (TNF), interleukin-6 (IL-6), interleukin-1 receptor antagonist (IL-1RA) and TNF soluble receptors were followed in bronchoalveolar lavage (BAL) fluid and blood from 10 HIV-seronegative patients with Pneumocystis carinii pneumonia (PCP) and compared with values found in healthy volunteers. During the acute phase of PCP, TNF but not IL-6 or IL-1beta was detectable in BAL fluid. At that time, plasma concentrations of the proinflammatory cytokines were low, whereas plasma concentrations of the anti-inflammatory cytokines were high. The ex vivo production capacity of proinflammatory cytokines was suppressed in the acute phase, in the blood as well as at the site of infection. During convalescence the production capacity of the blood cells normalized. The IL-1RA production capacity of the alveolar cells was also suppressed in the acute phase, but preserved in blood cells.


Subject(s)
AIDS-Related Opportunistic Infections/metabolism , Bronchoalveolar Lavage Fluid/chemistry , Cytokines/analysis , HIV Seropositivity/metabolism , Pneumonia, Pneumocystis/metabolism , Adult , Aged , Cytokines/blood , Female , Humans , Interleukin 1 Receptor Antagonist Protein , Interleukin-1/analysis , Interleukin-6/analysis , Male , Middle Aged , Sialoglycoproteins/analysis , Tumor Necrosis Factor-alpha/analysis
15.
Parasite Immunol ; 18(2): 103-9, 1996 Feb.
Article in English | MEDLINE | ID: mdl-9223163

ABSTRACT

Pfs48/45, a sexual stage parasite protein doublet of P. falciparum, is a target of antibodies which inhibit the development of the parasite in the mosquito. Twenty-eight (54%) out of 52 sera of gametocyte carriers from Cameroon reduced infectivity in the mosquito membrane feeding bioassay to less than 20% of the controls. These 52 sera were analysed by competition ELISAs for the presence of antibodies capable of competing the binding of six monoclonal antibodies (MoAbs) directed against five different epitopes on Pfs48/45. The percentage of these 52 Cameroon sera that competed with one of the MoAbs ranged from 13% (epitope I) to 33% (epitope IIc). Comparison of activity in the transmission-blocking assay (> or = 80%) and in the Pfs48/45 competition ELISA show a relative specificity of 100% (24 of 24) and a relative sensitivity of 75% (21 of 28). Non-blocking sera showed no competition with any of the MoAbs. These MoAbs were further used to study the diversity of epitopes among isolates of P. falciparum using a two-site ELISA. MoAbs against epitope I, III and V reacted with four different isolates whereas epitope II could be subdivided into three epitopes. None of the isolates reacted with MoAb 3G12 (epitope IV). Using these four different isolates, the competition ELISA titre varies from 1/20 to 1/80 and no significant differences are found between the isolates except for epitope II where only three out of 11 positives for epitope IIa were also positive for epitope IIc.


Subject(s)
Antibodies, Protozoan/blood , Antibodies, Protozoan/immunology , Malaria, Falciparum/immunology , Malaria, Falciparum/transmission , Membrane Glycoproteins/immunology , Protozoan Proteins/immunology , Adolescent , Adult , Animals , Anopheles/parasitology , Antibodies, Monoclonal , Antibody Specificity , Biological Assay , Cameroon , Child , Enzyme-Linked Immunosorbent Assay , Epitopes , Humans , Parasitology/methods
16.
Eur J Nucl Med ; 22(10): 1129-32, 1995 Oct.
Article in English | MEDLINE | ID: mdl-8542896

ABSTRACT

To study the effect of new therapeutic strategies, we developed an animal model to monitor the course and severity of experimental Pneumocystis carinii pneumonia (PCP) in rats. P. carinii density scores in Giemsa-stained impression smears were used to follow P. carinii load. Indium-111 labelled IgG scintigraphy and biodistribution, histology of paraffin-embedded tissue sections, lung/body weight (L/B wt) ratio and cell count and differentiation of broncho-alveolar lavage (BAL) fluid were used as parameters of host inflammatory response. Statistically significant differences in L/B wt ratio, number of neutrophils in BAL fluid, P. carinii density score, histological extent of inflammation and 111In-IgG accumulation in the lung were seen between the rats sacrificed at various time points. 111In-IgG accumulation in the lung correlated well with L/B wt ratio and P. carinii density score and correlated moderately with number of neutrophils in BAL fluid and with the histological extent of inflammation.


Subject(s)
Immunoglobulin G , Indium Radioisotopes , Pneumonia, Pneumocystis/diagnostic imaging , Radioimmunodetection/methods , Animals , Bronchoalveolar Lavage Fluid/cytology , Female , Immunoglobulin G/metabolism , Rats , Rats, Sprague-Dawley , Tissue Distribution
17.
Infect Immun ; 63(2): 467-71, 1995 Feb.
Article in English | MEDLINE | ID: mdl-7822011

ABSTRACT

By use of the parental hybridoma cell line 63F2A2 that produces specific antibodies of immunoglobulin isotype G1 (IgG1; 63F2A2.1) against Pfs230, we attempted to enrich for the synthesis of the downstream switch variant IgG2b and IgG2a monoclonal antibodies (MAbs) of the hybridoma cell line (63F2A2.2b and 63F2A2.2a, respectively). The parental IgG1 did not reduce the Plasmodium falciparum transmission in a bioassay irrespective of the presence of complement. MAbs 63F2A2.2b and 63F2A2.2a were effective in reducing the infectivity of P. falciparum parasites to Anopheles gambiae mosquitoes in membrane-feeding experiments. A transmission reduction of 91% was accomplished by the 63F2A2.2b switch variant, and a reduction of greater than 99% was accomplished by the 63F2A2.2a switch variant, but only in the presence of active human complement. Subsequently, the transmission-reducing effect of MAb 63F2A2.2b or 63F2A2.2a was confirmed in vitro by the rapid lysis of newly formed macrogametes or zygotes in the presence of active complement. MAb 63F2A2.1 did not lyse the newly formed macrogametes or zygotes irrespective of the presence of complement.


Subject(s)
Antibodies, Protozoan/immunology , Antigens, Protozoan/immunology , Immunoglobulin Isotypes/immunology , Malaria, Falciparum/transmission , Plasmodium falciparum/immunology , Protozoan Proteins/immunology , Animals , Anopheles/parasitology , Antibodies, Monoclonal/immunology , Antigens, Surface/immunology , Insect Vectors/parasitology , Malaria, Falciparum/prevention & control
18.
Exp Parasitol ; 80(1): 15-26, 1995 Feb.
Article in English | MEDLINE | ID: mdl-7529717

ABSTRACT

The activity of monoclonal antibodies (mAbs) that specifically recognize the Plasmodium falciparum sexual stage-specific protein Pfs230 was analyzed. All mAbs reacted with the surface of extracellular sexual forms of the parasite in a suspension immunofluorescence antibody reaction and precipitated the Pfs230 protein from an NP-40 extract of surface radioiodinated macrogametes/zygotes. Only mAb that bound complement blocked transmission, whereas mAb that did not bind complement but competed with the complement-binding mAb for binding to the same epitope did not block transmission. These mAbs were used to develop Pfs230-specific competition ELISAs to analyze epitope diversity and to analyze the binding characteristics of anti-Pfs230 antibodies in human serum. Transmission-blocking (TB) antibodies in test/field sera competed in the competition ELISA for binding with epitope-specific, labeled mAbs against Pfs230. At least five different epitope regions could be defined with the competition ELISAs. All 46 sera from gametocyte carriers immunoprecipitated the Pfs230 molecule, while 19 of these sera blocked transmission in the bioassay. Five of the transmission-blocking and one of the nonblocking sera competed with monoclonal antibodies. A method comparison analysis was used to determine agreement between reactions in a competitive ELISA and the TB activity examined in the bioassay. The index of agreement kappa between outcomes of the bioassay and ELISA was fair to poor (kappa = 0.25) but since its range includes values below 0 the relation between the data obtained by the bioassay and the competition ELISA can be explained by chance alone. The serological data did not reveal a correlation between immunoprecipitation of Pfs230 and TB activity.


Subject(s)
Antibodies, Protozoan/blood , Malaria, Falciparum/immunology , Plasmodium falciparum/immunology , Protozoan Proteins/immunology , Adolescent , Adult , Animals , Antibodies, Monoclonal/immunology , Antibody Specificity , Antigens, Protozoan/immunology , Antigens, Surface/immunology , Binding, Competitive , Blotting, Western , Child , Electrophoresis, Polyacrylamide Gel , Enzyme-Linked Immunosorbent Assay , Epitopes/immunology , Humans , Immune Sera/immunology
19.
Am J Trop Med Hyg ; 52(1): 60-5, 1995 Jan.
Article in English | MEDLINE | ID: mdl-7856826

ABSTRACT

Monoclonal antibodies (MAbs) 32F1 and 32F3 react with two independent epitopes of a protein doublet with molecular weights of 48 and 45 kilodaltons (kD) expressed on the surface of Plasmodium falciparum (Pfs48/45) macrogametes and zygotes; only 32F3 blocks transmission. These MAbs were used to develop a Pfs48/45-specific competition enzyme-linked immunosorbent assay (ELISA) using 32F1 to capture antigen and labeled 32F3 for quantification and analysis of the contribution of antibodies in human serum to transmission-blocking activity. A comparison analysis was used to determine agreement of competition ELISA titers and transmission-blocking activity as observed in the bioassay in three groups of serum samples: 37 from European travelers with previous exposure to malaria, 56 from gametocyte carriers, and 66 from schoolchildren from a malaria-endemic area in Cameroon. The index of agreement between outcomes of the ELISA and transmission-blocking assay in gametocyte carriers and in travelers was specifically defined as fair-to-moderate; in schoolchildren the agreement was not significant. The combined analysis of all sera showed a significant and fair-to-moderate agreement between the results of the competition ELISA and the transmission-blocking assay, with a relative specificity of 94% (of 105 cases negative in the transmission-blocking assay, 99 were also negative in the competition ELISA) and a relative sensitivity of 44% (of 54 cases positive in the transmission-blocking assay, 24 were also positive in the competition ELISA). This study shows that a positive C48/45-ELISA is indicative for transmission-blocking activity in the mosquito assay, while a negative result does not exclude transmission-blocking activity.


Subject(s)
Antibodies, Protozoan/blood , Carrier State/immunology , Enzyme-Linked Immunosorbent Assay/standards , Malaria, Falciparum/immunology , Plasmodium falciparum/immunology , Adolescent , Adult , Aged , Animals , Anopheles , Antibodies, Monoclonal/immunology , Antigens, Protozoan/immunology , Binding, Competitive , Child , Confidence Intervals , Humans , Immune Sera/immunology , Middle Aged , Sensitivity and Specificity
20.
Nephrol Dial Transplant ; 10(7): 1194-7, 1995.
Article in English | MEDLINE | ID: mdl-7478123

ABSTRACT

In 1991 and 1992 Pneumocystis carinii pneumonia (PCP) was diagnosed in 28 renal transplant recipients. The incidence of PCP in our renal transplant centre was remarkably increased from 1.1% before 1991 to 11.5% in 1991-1992. We compared 28 PCP patients with a control group of 27 renal transplant recipients, matched for transplantation day and without an episode of PCP. The mean age was significantly higher in the PCP group (50 +/- 13 versus 38 +/- 13 years). We observed no differences in basic immunosuppressive and rejection treatment nor in antibiotic consumption, number of hospitalization days, and incidence of CMV infection. In March 1993 we introduced PCP prophylaxis. More than 140 renal transplant recipients received co-trimoxazole, starting 1 day after transplantation and continued for a period of 4 months. To the time of writing no one in this group had developed PCP.


Subject(s)
Kidney Transplantation , Pneumonia, Pneumocystis/etiology , Adult , Female , Humans , Incidence , Male , Middle Aged , Pneumonia, Pneumocystis/epidemiology , Postoperative Complications , Retrospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...